SLC7A11 and head and neck cancer: Upregulation of SLC7A11, a member of cystine/glutamate antiporter, protected cancer cells from ferroptosis while SLC7A11 inhibition induced ferroptosis and enhanced cisplatin cytotoxicity in cisplatin-resistant head and neck cancer cells (Dixon et al., 2012; Roh et al., 2016).